CIK 0001885522
- Non-accelerated filer
- Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 844367680
- Phone
- +1 857-760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- 4 Planned sale Aurora Daljit Singh sold 114,703 shares at $2.68 ($307,026)
- 4 Open-market buy Director bought 1,915,700 shares at $2.61 ($4,999,977)
- 4 Open-market buy 10% owner bought 1,915,700 shares at $2.61 ($4,999,977)
- 4 Open-market buy 10% owner bought 1,915,700 shares at $2.61 ($4,999,977)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift President gave 13,202 shares (gift)
- 4 Planned sale BERNS PAUL L sold 13,871 shares at $1.69 ($23,468)
- 4 Planned sale Milligan Michael Lee sold 1,978 shares at $1.69 ($3,351)
- 4 Planned sale Chief Strategy Officer sold 8,565 shares at $1.68 ($14,347)
- 4 Planned sale Head of R&D sold 5,614 shares at $1.67 ($9,383)
- 4 Planned sale President sold 8,048 shares at $1.67 ($13,477)
Page 2 of 6 · 118 filings